Literature DB >> 19474297

Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses.

Donna K Slonim1, Keiko Koide, Kirby L Johnson, Umadevi Tantravahi, Janet M Cowan, Zina Jarrah, Diana W Bianchi.   

Abstract

To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples. Functional pathway analysis highlighted the importance of oxidative stress, ion transport, and G protein signaling in the DS fetuses. Further evidence supporting these results was derived by correlating the observed gene expression patterns to those of small molecule drugs via the Connectivity Map. Our results suggest that there are secondary adverse consequences of DS evident in the second trimester, leading to testable hypotheses about possible antenatal therapy for DS.

Mesh:

Year:  2009        PMID: 19474297      PMCID: PMC2687148          DOI: 10.1073/pnas.0903909106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  The protein information resource (PIR).

Authors:  W C Barker; J S Garavelli; H Huang; P B McGarvey; B C Orcutt; G Y Srinivasarao; C Xiao; L S Yeh; R S Ledley; J F Janda; F Pfeiffer; H W Mewes; A Tsugita; C Wu
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

3.  InterPro--an integrated documentation resource for protein families, domains and functional sites.

Authors:  R Apweiler; T K Attwood; A Bairoch; A Bateman; E Birney; M Biswas; P Bucher; L Cerutti; F Corpet; M D Croning; R Durbin; L Falquet; W Fleischmann; J Gouzy; H Hermjakob; N Hulo; I Jonassen; D Kahn; A Kanapin; Y Karavidopoulou; R Lopez; B Marx; N J Mulder; T M Oinn; M Pagni; F Servant; C J Sigrist; E M Zdobnov
Journal:  Bioinformatics       Date:  2000-12       Impact factor: 6.937

4.  Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.

Authors:  M Ashburner; C A Ball; J A Blake; D Botstein; H Butler; J M Cherry; A P Davis; K Dolinski; S S Dwight; J T Eppig; M A Harris; D P Hill; L Issel-Tarver; A Kasarskis; S Lewis; J C Matese; J E Richardson; M Ringwald; G M Rubin; G Sherlock
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

5.  Gene expression profile of trisomy 21 placentas: a potential approach for designing noninvasive techniques of prenatal diagnosis.

Authors:  Susan J Gross; Jose C Ferreira; Bernice Morrow; Peer Dar; Birgit Funke; Dineo Khabele; Irwin Merkatz
Journal:  Am J Obstet Gynecol       Date:  2002-08       Impact factor: 8.661

6.  Whither Down syndrome critical regions?

Authors:  B L Shapiro
Journal:  Hum Genet       Date:  1997-03       Impact factor: 4.132

7.  Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin.

Authors:  K Zaman; H Ryu; D Hall; K O'Donovan; K I Lin; M P Miller; J C Marquis; J M Baraban; G L Semenza; R R Ratan
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

Review 8.  Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease.

Authors:  A C Allison; R Cacabelos; V R Lombardi; X A Alvarez; C Vigo
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2001-10       Impact factor: 5.067

9.  Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype.

Authors:  J R Korenberg; H Kawashima; S M Pulst; T Ikeuchi; N Ogasawara; K Yamamoto; S A Schonberg; R West; L Allen; E Magenis
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

10.  Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.

Authors:  Kenji Amano; Haruhiko Sago; Chiharu Uchikawa; Taishi Suzuki; Svetlana E Kotliarova; Nobuyuki Nukina; Charles J Epstein; Kazuhiro Yamakawa
Journal:  Hum Mol Genet       Date:  2004-05-11       Impact factor: 6.150

View more
  61 in total

Review 1.  Prenatal pharmacotherapy for fetal anomalies: a 2011 update.

Authors:  Lisa Hui; Diana W Bianchi
Journal:  Prenat Diagn       Date:  2011-06-03       Impact factor: 3.050

2.  Novel neurodevelopmental information revealed in amniotic fluid supernatant transcripts from fetuses with trisomies 18 and 21.

Authors:  Lisa Hui; Donna K Slonim; Heather C Wick; Kirby L Johnson; Keiko Koide; Diana W Bianchi
Journal:  Hum Genet       Date:  2012-07-03       Impact factor: 4.132

Review 3.  Cell-free fetal nucleic acids in amniotic fluid.

Authors:  L Hui; D W Bianchi
Journal:  Hum Reprod Update       Date:  2010-10-05       Impact factor: 15.610

Review 4.  From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges.

Authors:  Diana W Bianchi
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

5.  Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery.

Authors:  Roberto Romero; Shali Mazaki-Tovi; Edi Vaisbuch; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Ricardo Gomez; Jyh Kae Nien; Bo Hyun Yoon; Moshe Mazor; Jingqin Luo; David Banks; John Ryals; Chris Beecher
Journal:  J Matern Fetal Neonatal Med       Date:  2010-05-26

6.  RNA-Seq and expression microarray highlight different aspects of the fetal amniotic fluid transcriptome.

Authors:  Lillian M Zwemer; Lisa Hui; Heather C Wick; Diana W Bianchi
Journal:  Prenat Diagn       Date:  2014-06-29       Impact factor: 3.050

7.  Amniotic fluid RNA gene expression profiling provides insights into the phenotype of Turner syndrome.

Authors:  Lauren J Massingham; Kirby L Johnson; Thomas M Scholl; Donna K Slonim; Heather C Wick; Diana W Bianchi
Journal:  Hum Genet       Date:  2014-05-22       Impact factor: 4.132

8.  Proof of concept study to assess fetal gene expression in amniotic fluid by nanoarray PCR.

Authors:  Lauren J Massingham; Kirby L Johnson; Diana W Bianchi; Shermin Pei; Inga Peter; Janet M Cowan; Umadevi Tantravahi; Tom B Morrison
Journal:  J Mol Diagn       Date:  2011-08-09       Impact factor: 5.568

Review 9.  The amniotic fluid transcriptome as a guide to understanding fetal disease.

Authors:  Lillian M Zwemer; Diana W Bianchi
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-13       Impact factor: 6.915

Review 10.  Getting started in gene expression microarray analysis.

Authors:  Donna K Slonim; Itai Yanai
Journal:  PLoS Comput Biol       Date:  2009-10-30       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.